|Podcasts|August 2, 2018
Episode 14: Emerging Biotech in NYC
Author(s)Michelle Maskaly, Christen Harm
Nancy Thornberry, CEO of Kallyope, talks with Michelle Maskaly and Christen Harm about New York City as an emerging hotspot for biotech incubators, and the challenges and opportunities related to space, location, recruitment, and funding.
Advertisement
Nancy Thornberry, CEO of Kallyope, talks with Michelle Maskaly and Christen Harm about New York City as an emerging hotspot for biotech incubators, and the challenges and opportunities related to space, location, recruitment, and funding.
You can listen and/or download the episode on SoundCloud, or directly through iTunes, GooglePlay, Stitcher, and Overcast.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
AstraZeneca Shares Drop Following Wainua’s Failed Heart Disease Trial
2
Novartis to Layoff 322 NJ Employees: Report
3
Pharmaceutical Executive Daily: FDA Approves Subcutaneous Sarclisa Escena
4
FDA Approves Subcutaneous Sarclisa Escena for Multiple Myeloma
5